Diagnostic tests for hepatitis C

Journal of Hepatology, Supplement

Volumn 31, Issue 1, 1999, Pages 71-79

  Pawlotsky, Jean Michel ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

Diagnostic tests; Hepatitis C; Molecular biology based assays; Serological assays

Indexed keywords

HEPATITIS C ANTIBODY; HEPATITIS C ANTIGEN; VIRUS RNA;

ANTIBODY DETECTION; CONFERENCE PAPER; DIAGNOSTIC TEST; ENZYME IMMUNOASSAY; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROTYPING; VIRUS DETECTION; VIRUS LOAD; VIRUS REPLICATION;

EID: 0033458948     PISSN: 01695185     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0168-8278(99)80378-x     Document Type: Conference Paper

References (79)

1. Wang JT, Wang TH, Sheu JC, Lin SM, Lin JT, Chen DS. Effects of anticoagulants and storage of blood samples on efficacy of the polymerase chain reaction assay for hepatitis C virus. J Clin Microbiol 1992: 30: 750-753.
2. Busch MP, Wilber JC, Johnson P, Tobler L, Evans CS. Impact of specimen handling and storage on detection of hepatitis C virus RNA. Transfusion 1992: 32: 42025.
3. Cuypers HT, Bresters D, Winkel IN, Reesink HW, Weiner AJ, Houghton M et al. Storage conditions of blood samples and primer selection affect the yield of cDNA polymerase chain reac-tion products of hepatitis C virus. J Clin Microbiol 1992: 30: 3220-3224.
4. Halfon P, Khiri H, Gerolami V, Bourlière M, Féryn M, Reynier P et al. Impact of various handling and storage conditions on quantitative detection of hepatitis C virus RNA. J Hepatol 1996: 25:307-311.
5. Davis GL, Lau JY, Urdea MS, Neuwald PD, Wilber JC, Lindsay K et al. Quantitative detection of hepatitis C virus RNA with a solid-phase signal amplification method: definition of optimal conditions for specimen collection and clinical application in interferon-treated patients. Hepatology 1994: 19: 1337-1341.
6. Damen M, Sillekens P, Sjerps M, Melsert R, Frantzen I, Reesink HW et al. Stability of hepatitis C virus RNA during specimen handling and storage prior to NASBA amplification. J Virol Methods 1998: 72: 175-184.
7. Zaaijer HL, Cuypers HT, Reesink HW, Winkel IN, Gerken G, Lelie PN. Reliability of polymerase chain reaction for detection of hepatitis C virus. Lancet 1993: 341: 722-724.
8. French Study Group for the Standardization of Hepatitis C Virus PCR. Improvement of hepatitis C virus RNA polymerase chain reaction through a multicentre quality control study. J Virol Methods 1994: 49: 79-88.
9. Damen M, Cuypers HT, Zaaijer HL, Reesink HW, Schaasberg WP, Gerlich WH et al. International collaborative study on the second EUROHEP HCV-RNA reference panel. J Virol Methods 1996: 58: 175-185.
10. Alter HJ. New kit on the block: evaluation of second-generation assays for detection of antibody to the hepatitis C virus. Hepatology 1992: 15: 350-353.
11. Nakatsuji Y, Matsumoto A, Tanaka E, Ogata H, Kiyosawa K. Detection of chronic hepatitis C virus infection by four diagnostic systems: first-generation and second-generation enzymelinked immunosorbent assay, second-generation recombinant immunoblot assay and nested polymerase chain reaction analysis. Hepatology 1992: 16: 300-305.
12. Frost EH. Investigation of sera reactive to hepatitis C virus by second-generation enzyme immunoassay. J Clin Microbiol 1993: 31: 163-164.
13. Chaudary RK, McLean C. Detection of antibody to hepatitis C virus by second-generation enzyme immunoassay. Am J Clin Pathol 1993: 99: 702-704.
14. Shev S, Foberg U, Fryden A, Hermodsson S, Lindh G, Lindholm A et al. Second-generation hepatitis C Elisa antibody tests confirmed by the four-antigen recombinant immunoblot assay correlate well with hepatitis C viremia and chronic liver disease in Swedish blood donors. Vox Sang 1993: 65: 32-37.
15. Aoki SK, Kuramoto IK, Anderson S, Schoening V, Rodriguez R, Fernando L et al. Evidence that use of a second-generation hepatitis C antibody assay prevents additional cases of transfusion-transmitted hepatitis. J Viral Hep 1994: 1: 73-77.
16. Couroucé AM, Le Marrec N, Girault A, Ducamp S, Simon N. Anti-hepatitis C virus (anti-HCV) seroconversion in patients undergoing hemodialysis: comparison of second- and third-generation anti-HCV assays. Transfusion 1994: 34: 790-795.
17. Vrielink H, Zaaijer HL, Reesink HW, van der Pool CL, Cuypers HTM, Lelie PN. Sensitivity and specificity of three third-generation anti-hepatitis C virus ELISAs. Vox Sang 1995: 69: 14-17.
18. Barrera JM, Francis B, Ercilla G, Nelles M, Achord D, Darner J et al. Improved detection of anti-HCV in post-transfusion hepatitis by a third-generation ELISA: Vox Sang 1995: 68: 15-18.
19. Lee SR, Wood CL, Lane MJ, Francis B, Gust C, Higgs CM et al. Increased detection of hepatitis C virus infection in commercial plasma donors by a third-generation screening assay. Transfusion 1995: 35: 845-849.
20. Lavanchy D, Steinmann J, Moritz A, Frei PC. Evaluation of a new automated third-generation anti-HCV enzyme immunoassay. J Clin Lab Anal 1996: 10: 269-276.
21. Atrah HI, Ahmed MM. Hepatitis C virus seroconversion by a third-generation ELISA screening test in blood donors. J Clin Pathol 1996: 49: 254-255.
22. Huber KR, Sebesta C, Bauer K. Detection of common hepatitis C virus subtypes with a third-generation enzyme immunoassay. Hepatology 1996: 24: 471-473.
23. Vrielink H, Reesink HW, van den Burg PI, Zaaijer HL, Cuypers HTM, Lelie PN et al. Performance of three generations of antihepatitis C virus enzyme-linked immunosorbent assays in donors and patients. Transfusion 1997: 37: 845-849.
24. Pawlotsky JM, Maisonneuve P, Duval J, Dhumeaux D, Noël L. Significance of NS5 "indeterminate" third-generation anti-hepatitis C virus serological assays. Transfusion 1995: 35: 453154.
25. Lesniewski R, Okasinski G, Carrick R, van Sant C, Desai S, Johnson R et al. Antibody to hepatitis C virus second envelope (HCV-E2) glycoprotein: a new marker of HCV infection closely associated with viremia. J Med Virol 1995: 45: 41522.
26. Fourmilier-Jacob A, Lunel F, Cahour A, Cresta P, Frangeul L, Perrin M et al. Antibody responses to hepatitis C envelope proteins in patients with acute or chronic hepatitis C. J Med Virol 1996: 50: 159-167.
27. De Medina M, Hill M, Sullivan HO, Leclerq B, Pcnnell JP, Jeffers L et al. Detection of anti-hepatitis C virus antibodies in patients undergoing dialysis by utilizing a hepatitis C virus 3.0 assay: correlation with hepatitis C virus RNA. J Lab Clin Med 1998: 132: 73-75.
28. Zylberberg H, Pol S. Reciprocal interactions between human immunodeficiency virus and hepatitis C virus infections. Clin Infect Dis 1996: 23: 1117-1125.
29. Quaranta JF, Delaney SR, Alleman S, Cassuto JP, Dellamonica P, Allain JP. Prevalence of antibody to hepatitis C virus (HCV) in HIV-1-infected patients (Nice SEROCO cohort). J Med Virol 1994: 42: 29-32.
30. Ragni MV, Ndimbie OK, Rice EO, Bontempo FA, Nedjar S. The presence of hepatitis C virus (HCV) antibody in human immunodeficiency virus-positive hémophilie men undergoing HCV "seroreversion". Blood 1993: 82: 1010-1015.
31. Bukh J, Wantzin P, Krogsgaard K, Knudsen F, Purcell RH, Miller RH et al. High prevalence of hepatitis C virus (HCV) RNA in dialysis patients: failure of commercially available antibody tests to identify a significant number of patients with HCV infection. J Infect Dis 1993: 168: 1343-1348.
32. Preiksaitis JK, Cockfield SM, Fenton JM, Burton NI, Chui LW. Serologie responses to hepatitis C virus in solid organ transplant recipients. Transplantation 1997: 64: 1775-1780.
33. Donegan E, Wright TL, Roberts J, Ascher NL, Lake JR, Neuwald P et al. Detection of hepatitis C after liver transplantation. Four sérologie tests compared. Am J Clin Pathol 1995: 104: 673679.
34. Johnson RJ, Gretch DR, Yamabe H, Hart J, Bacchi CE, Hartwell P et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 1993: 328: 465470.
35. Consensus Development Panel. National Institutes of Health Consensus Development Conference Panel Statement: Management of hepatitis C. Hepatology 1997: 26 (suppl. 1): 2S-10S.
36. Pawlotsky JM, Bastie A, Lonjon I, Rémiré J, Darthuy F, Soussy CJ et al. What technique should be used for routine detection and quantification of HBV DNA in clinical samples? J Virol Methods 1997: 65: 245-253.
37. van der Poel CL, Cuypers HTM, Reesink HW, Weiner AJ, Quan S, diNello R et al. Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay. Lancet 1991: 337: 317-319.
38. Pawlotsky JM, Bastie A, Pellet C, Rémiré J, Darthuy F, Wolfe L et al. Significance of indeterminate third-generation hepatitis C virus recombinant immunoblot assay. J Clin Microbiol 1996: 34: 80-83.
39. Sayers MH, Gretch DR. Recombinant immunoblot and polymerase chain reaction testing in volunteer whole blood donors screened by a multi-antigen assay for hepatitis C virus antibodies. Transfusion 1993: 33: 809-813.
40. Chau KH, Dawson GJ, Mushahwar IK, Gutierrez RA, Johnsson RG, Lesniewski RR et al. IgM antibody response to hepatitis C virus antigens in acute and chronic posttransfusion non-A, nonB hepatitis. J Virol Methods 1991: 34: 343-352.
41. Quiroga JA, Campillo M, Castillo I, Bartolomé J, Porres JC, Carreno V. IgM antibody to hepatitis C virus in acute and chronic hepatitis C. Hepatology 1991: 14: 383.
42. Hellström ÜB, Sylvan SPE, Decker RH, Sönnerborg A. Immunoglobulin M reactivity towards the immunologically active region sp75 of the core protein of hepatitis C virus (HCV) in chronic HCV infection. J Med Virol 1993: 39: 325-332.
43. Pawlotsky JM, Darthuy F, Rémiré J, Pellet C, Udin L, Stuyver L et al. Significance of anti-hepatitis C virus core IgM antibodies in patients with chronic hepatitis C. J Med Virol 1995:47:285-291.
44. Pawlotsky JM, Roudot-Thoraval F, Pellerin M, Bastie A, Vitrât D, Duval J et al. Significance of anti-HCV core IgM in patients with chronic hepatitis C treated with interferon alpha. Hepatology 1996: 24: 391 A.
45. Martell M, Gomez J, Esteban JI, Sauleda S, Quer J, Cabot B et al. High-throughput real-time reverse transcription-PCR quantitation of hepatitis C virus RNA. J Clin Microbiol 1999: 37: 327332.
46. Takeuchi T, Katsume A, Tanaka T, Abe A, Inoue K, TsukiyamaKohara K et al. Real-Time detection system for quantification of hepatitis C virus genome. Gastroenterology 1999: 116: 636-642.
47. Gretch DR. Diagnostic tests for hepatitis C. Hepatology 1997: 26 (Suppl. 1): 43S-47S.
48. Wolfe L, Tamatsukuri S, Sayada C, Ryff JC. Detection of HCV RNA in serum using a single-tube, single-enzyme PCR in combination with a colorimetric microwell assay. In: Groupe Français d'Etudes Moléculaires des Hépatites (GEMHEP), editor. Hepatitis C virus: new diagnostic tools. Paris: John Libbey Eurotext; 1994. p. 83-94.
49. Albaladejo J, Alonso R, Antinozzi R, Bogard M, Bourgault AM, Colucci G et al. Multicenter evaluation of thé COBAS AMPLICOR HCV assay, an integrated PCR system for rapid detection of hepatitis C virus RNA in the diagnostic laboratory. J'Clin Microbiol 1998: 36: 862-865.
50. Tong MJ, Blatt LM, Conrad A, Hur Y, Russell J, El-Farra NS et al. The changes in quantitative HCV RNA titers during interferon alpha-2b therapy in patients with chronic hepatitis C infection. Am J Gastroenterol 1998: 93: 601-605.
51. Tanaka E, Kiyosawa K, Matsumoto A, Kashiwakuma T, Hasegawa A, Mori H et al. Serum levels of hepatitis C virus core protein in patients with chronic hepatitis C treated with interferon alpha. Hepatology 1996: 23: 1330-1333.
52. Orito E, Mizokami M, Tanaka T, Lau JY, Suzuki K, Yamauchi M et al. Quantification of serum hepatitis C virus core protein level in patients chronically infected with different hepatitis C virus genotypes. Gut 1996: 39: 876-880.
53. Urdea MS. Quantification of hepatitis C virus RNA: clinical applications of the branched DNA assay. In: Groupe Français d'Etudes Moléculaires des Hépatites (GEMHEP), editor. Hepatitis C virus: genetic heterogeneity and viral load. Paris: John Libbey Eurotext; 1997. p. 73-78.
54. Roth WK, Lee JH, Rüster B, Zeuzem S. Comparison of two quantitative hepatitis C virus reverse transcriptase PCR assays. J Clin Microbiol 1996: 34: 261-264.
55. Collins ML, Zayati C, Detmer JJ, Daly B, Kolberg JA, Cha TA et al. Preparation and characterization of RNA standards for use in quantitative branched DNA hybridization assays. Anal Biochem 1995: 226: 120-129.
56. Detmer J, Lagier R, Flynn J, Zayati C, Kolberg J, Collins M et al. Accurate quantification of hepatitis C virus (HCV) RNA from all HCV genotypes by using branched DNA technology. J Clin Microbiol 1996: 34: 901-907.
57. Pawlotsky JM, Martinot-Peignoux M, Bastie A, Le Breton V, Darthuy F, Rémiré J et al. Quantification of hepatitis C virus RNA in serum by branched DNA-based signal amplification assays. J Virol Methods 1999: in press.
58. Roth WK, Lee JH, Rüster B, Zeuzem S. Comparison of two quantitative hepatitis C virus reverse transcriptase PCR assays. J Clin Microbiol 1996: 34: 261-264.
59. Hadziyannis E, Fried MW, Nolle FS. Evaluation of two methods for quantitation of hepatitis C virus RNA. Mol Diagn 1997: 2: 39(6.
60. Pawlotsky JM. Measuring hepatitis C viremia in clinical samples: can we trust the assays? Hepatology 1997: 26: 1-4.
61. McHutchison JG, Gordon SC, Schiff ER, Shiffman ML, Lee WM, Rustgi VK et al. Interferon alpha-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med 1998: 339: 1485-1492.
62. Poynard T, Marcellin P, Lee SS, Niederau C, Minuk GS, Ideo G et al. Randomised trial of Interferon alpha-2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha-2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. Lancet 1998: 352: 1426-1432.
63. Fang JWS, Albrecht JK, Jacobs S, Lau JYN. Quantification of serum hepatitis C virus RNA. Hepatology 1999: 29: 997-998.
64. Simmonds P. Variability of hepatitis C virus. Hepatology 1995: 21: 570-583.
65. Bukh J, Miller RH, Purcell RH. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin Liver Dis 1995: 15: 41-63.
66. Maertens G, Stuyver L. Genotypes and genetic variation of hepatitis C virus. In: Harrison TJ, Zuckerman AJ, editors. The Molecular Medicine of Viral Hepatitis. New York: John Wiley & Sons; 1997. p. 183-233.
67. Okamoto H, Kobata S, Tokita H, Inoue T, Woodfield GD, Holland PV et al. A second-generation method of genotyping hepatitis C virus by the polymerase chain reaction with sense and antisense primers deduced from the core gene. J Virol Methods 1996: 57: 31-45.
68. Davidson F, Simmonds P, Ferguson JC, Jarvis LM, Dow BC, Follett EAC et al. Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5' non coding region. J Gen Virol 1995: 76: 1197-1204.
69. Stuyver L, Rossau R, Wyseur A, Duhamel M, Vanderborght B, Van Heuverswyn H et al. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol 1993:74: 1093-1102.
70. Biasin MR, Fiordalisi G, Zanella I, Cavicchini A, Marchelle G, Infantolino D. A DNA hybridization method for typing hepatitis C virus genotype 2c. J Virol Methods 1997: 65: 307-315.
71. Battacherjee V, Prescott LE, Pike I, Rodgers B, Bell H, El-Zayadi AR et al. Use of NS-4 peptides to identify type-specific antibody to hepatitis C virus genotypes 1, 2, 3, 4, 5 and 6. J Gen Virol 1995: 76: 1737-1748.
72. Dixit V, Quan S, Martin P, Larson D, Brezina M, DiNello R et al. Evaluation of a novel serotyping system for hepatitis C virus: strong correlation with standard genotyping methodologies. J Clin Microbiol 1995: 33: 2978-2983.
73. Mizoguchi N, Mizokami M, Orito E, Shibata H, Shibata H. Serologically defined genotypes of hepatitis C virus among Japanese patients with chronic hepatitis C. J Virol Methods 1996: 58: 71-79.
74. Pawlotsky JM, Prescott L, Simmonds P, Pellet C, Laurent-Puig P, Labonne C et al. Serological determination of hepatitis C virus genotype: comparison with a standardized genotyping assay. J Clin Microbiol 1997: 35: 1734-1739.
75. Lee JH, Roth WK, Zeuzem S. Evaluation and comparison of different hepatitis C virus genotyping and serotyping assays. J Hepatol 1997: 26: 1001-1009.
76. Pawlotsky JM, Lonjon I, Hézode C, Raynard B, Darthuy F, Ré miré J et al. What strategy should be used for diagnosis of hepatitis C virus infection in clinical laboratories. Hepatology 1998: 27: 1700-1702.
77. Dhumeaux D, Doffoel M, Galmiche JP. French consensus conference on hepatitis C: screening and treatment. J Hepatol 1997: 27: 941-944.
78. Lam NP, Neumann AU, Gretch DR, Wiley TE, Perelson AS, Layden TJ. Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alpha. Hepatology 1997:26:226-231. 79. Neumann AU, Lam NP, Dahari H, Gretch DR, Wiley TE, Layden TJ et al. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-a therapy. Science 1998: 282: 103-107.
79. Pawlotsky JM, Dahari H, Conrad A, Lonjon I, Hézode C, Germanidis G et al. Effect of intermittent interferon (IFN), daily IFN and IFN plus ribavirin induction therapy on hepatitis C virus (HCV) genotype Ib replication kinetics and clearance. Hepatology 1998: 28: 288A.